email   Email Us: phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2637-4706

Drug Designing & Intellectual Properties International Journal

Mini Review(ISSN: 2637-4706)

Depression in Pregnancy: Treat or Do Not Treat?

Volume 2 - Issue 1

Amani Mohsen*

  • Author Information Open or Close
    • Woman’s Health Center, Médecins Sans Frontières, Beirut, Lebanon

    *Corresponding author: Amani Mohsen, Woman’s Health Center, Médecins Sans Frontières, Beirut, Lebanon

Received: July 19, 2018;   Published: July 25, 2018

DOI: 10.32474/DDIPIJ.2018.02.000128

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Globally, mental health disorders are increasingly prevalent worldwide with depression particularly contributed to the largest percentage of global disability (7.5% of all years lived with disability in 2015). It is more common in females than males affecting 4 -7% of women in reproductive age group [1]. Women with mild depression are treated with cognitive based therapy and antidepressants are used depending on the severity of the symptoms [2]. Utilizing antidepressants preconception and during pregnancy was assessed in wide range of studies to evaluate the risk of associated congenital anomalies. Ornoy et al reviewed the association between tricyclic antidepressants (TCA) and congenital anomalies. Early studies showed slight increase in the associated risk however the following large studies showed no association [2].

Mini Review| Refernces|